Lipocine files Form 3 initial beneficial ownership statement for director Michael Grissinger

Lipocine Inc. director Michael Grissinger filed an initial Form 3 beneficial ownership statement on August 7, 2026. The filing relates to a reporting event that occurred on August 3, 2026. This information was published via EDGAR by Lipocine Inc.

Lipocine director Michael Grissinger filed an initial Form 3 on Aug. 7 tied to an Aug. 3 reporting event. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036573), on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here